Read about the Global Fund’s decision in December 2013 to approve funding for some interim applicants and to renew funding for some grants:
The Global Fund Board has approved a $32.6 million grant to respond to the continued challenges posed by multi-drug resistant TB in Somalia, acknowledging the security and corruption concerns that make health service delivery in the country extraordinarily difficult.
Both interim and renewal funding for a total $79 million have been approved to assist in Tanzania's efforts to combat an HIV epidemic that has infected an estimated 1.6 million of the country's nearly 48 million people.
The Global Fund has approved $4.2 million in incremental funding for Phase 2 of a TB grant to Yemen despite concerns about performance in Phase 1 and serious risks associated with programme implementation.
Phase 2 of a health systems strengthening (HSS) grant worth $36.2 milllion in incremental funding for Viet Nam will scale up activities and address key bottlenecks. The principal recipient (PR) for Grant VTN-011-G10-S is the Ministry of Health.
Kenya will use the bulk of two incremental funding Phase 2 grants worth $79.7 million to purchase and distribute 7.5 million new long-lasting insecticide-treated nets (LLINs), 17.2 million courses of artemisinin combination therapy (ACT) and 21.8 million rapid diagnostic test kits.
Guatemala is trying to move from malaria control to malaria elimination. The Global Fund recently approved $10.8 million in incremental funding for the next implementation period of malaria grant GUA-M-MSPAS, for which the principal recipient (PR) is the Ministry of Health.
Phase 2 of two malaria grants worth $28.9 million will scale up malaria prevention and treatment programmes in Sierra Leone, which is still rebuilding following a devastating civil war.
The Global Fund Board recently approved $24.5 million in renewal funding for an HIV grant and $8.5 million for a TB grant in Eritrea, both administered by the Ministry of Health.